Hepatitis C
- 1 January 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 24 (7), 661-672
- https://doi.org/10.2165/00019053-200624070-00005
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- Divining the role of liver biopsy in hepatitis CJournal of Hepatology, 2005
- Experts' opinions on the role of liver biopsy in HCV infection: A Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.)Journal of Hepatology, 2005
- Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trialJournal of Viral Hepatitis, 2005
- Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis CPharmacoEconomics, 2004
- Monitoring of viral levels during therapy of hepatitis CHepatology, 2002
- The Cost Effectiveness of Combination Antiretroviral Therapy for HIV DiseaseNew England Journal of Medicine, 2001
- EASL International Consensus Conference on Hepatitis CParis, 26–27 February 1999Consensus StatementJournal of Hepatology, 1999
- Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosisHepatology, 1998
- Natural history of hepatitis CHepatology, 1997
- Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosisJournal of Hepatology, 1996